Questioning Authority: French Court Overturns Health Agency's Diabetes Guidelines, Citing Conflict Of Interest Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
The French court's action may force the country's regulatory bodies to take a closer look at their links with the pharmaceutical industry and reflects further fall-out from the Mediator scandal.